Experimental drug combination shows early effectiveness in advanced kidney cancer
An experimental drug combination may help overcome treatment resistance in advanced kidney cancer, according to early results from a first-in-human clinical trial led by Mayo Clinic researchers.
Jun 5, 2026
0
1









